Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal

Published:2015-06-01 Issue:3 Volume:42 Page:356-364
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ben-Horin S.¹²,Chowers Y.³,Ungar B.¹,Kopylov U.¹²,Loebstein R.²⁴,Weiss B.²⁵,Eliakim R.¹²,Del Tedesco E.⁶,Paul S.⁷,Roblin X.⁶

Affiliation:

1. Department of Gastroenterology; Sheba Medical Center; Tel Hashomer Israel

2. Sackler School of Medicine; Tel-Aviv University; Tel Aviv-Yafo Israel

3. Rambam Health Care Campus & Bruce Rappaport School of Medicine; Technion Institute of Technology; Haifa Israel

4. Institute of Clinical Pharmacology; Sheba Medical Center; Tel Hashomer Israel

5. Edmond & Lily Safra Children's Hospital; Tel Hashomer Israel

6. Department of Gastro-Enterology; INSERM CIC 1408; Paris France

7. Department of Immunology; INSERM CIC 1408; Paris France

Funder

Leona M. and Harry B. Helmsley Charitable Trust

Sheba MEdical Center

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13268/fullpdf

Reference22 articles.

1. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial;Hanauer;Lancet,2002

2. Infliximab maintenance therapy for fistulizing Crohn's disease;Sands;N Engl J Med,2004

3. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

4. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease;Maser;Clin Gastroenterol Hepatol,2006

5. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease;Karmiris;Gastroenterology,2009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

2. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

3. Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategies;Scandinavian Journal of Gastroenterology;2023-11-14

4. Immunomodulators after the discontinuation of anti‐tumor necrosis factor‐alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study;Journal of Gastroenterology and Hepatology;2023-10-12

5. Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study;Clinical Pharmacology & Therapeutics;2023-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3